Oral probiotic activities and biosafety of Lactobacillus gasseri HHuMIN D by Mann, Soyon et al.
Mann et al. Microb Cell Fact           (2021) 20:75  
https://doi.org/10.1186/s12934-021-01563-w
RESEARCH
Oral probiotic activities and biosafety 
of Lactobacillus gasseri HHuMIN D
Soyon Mann1, Myeong Soo Park2, Tony V. Johnston3, Geun Eog Ji2, Keum Taek Hwang1* and Seockmo Ku3*  
Abstract 
Background: Lactobacillus spp. have been researched worldwide and are used in probiotics, but due to difficulties 
with laboratory cultivation of and experimentation on oral microorganisms, there are few reports of Lactobacillus spp. 
being isolated from the oral cavity and tested against oral pathogens. This research sought to isolate and determine 
the safety and inhibitory capabilities of a Lactobacillus culture taken from the human body.
Results: One organism was isolated, named “L. gasseri HHuMIN D”, and evaluated for safety. A 5% dilution of L. gasseri 
HHuMIN D culture supernatant exhibited 88.8% inhibition against halitosis-producing anaerobic microorganisms and 
the organism itself exhibited powerful inhibitory effects on the growth of 11 oral bacteria. Hydrogen peroxide pro-
duction reached 802 μmol/L after 12 h and gradually diminished until 24 h, it efficiently aggregated with P. catoniae 
and S. sanguinis, and it completely suppressed S. mutans-manufactured artificial dental plaque. L. gasseri HHuMIN 
D’s KB cell adhesion capacity was 4.41 cells per cell, and the cell adhesion of F. nucleatum and S. mutans diminished 
strongly in protection and displacement assays.
Conclusion: These results suggest that L. gasseri HHuMIN D is a safe, bioactive, lactobacterial food ingredient, starter 
culture, and/or probiotic microorganism for human oral health.
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Introduction
Oral diseases are acute and chronic with a high preva-
lence globally, and oral health is a primary component 
of human health sustenance. Oral health is associated 
with a wide variety of illnesses and disorders, including 
dental caries, periodontal disease, tooth loss, oral cancer, 
oral symptoms of HIV infection, oral-dental trauma, and 
birth defects such as noma and cleft lip. Oral diseases 
cause suffering and disability to millions of Americans, 
costing taxpayers billions of dollars annually, according to 
the Centers for Disease Control and Prevention (CDC). 
According to a survey published in 2019, more than 
40 percent of US adults report having felt pain in their 
mouths, and more than 80 percent have had at least one 
cavity by age 34. [1]. The 2015 Global Burden of Disease 
Survey estimated that about 3.5 billion people worldwide 
experience oral illnesses [2] and the World Health Organ-
ization (WHO) reports that millions of individuals suffer 
immensely from unhealthy oral cavities. Over the past 
30 years, the global burden of tooth decay has remained 
largely unchanged and the total burden of oral disease 
will rise as a result of population growth and aging. Since 
the Tokyo Declaration on Dental Care and Oral Health 
for Healthy Lifetime, numerous oral health enhancement 
practices, including discussion of the overall value of oral 
health, the improvement of dental treatment systems, 
and the establishment of oral health programs, have been 
introduced by academia and industry [3].
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Dental caries is caused by acid, formed by bacte-
ria attached to the tooth’s surface, which corrodes the 
enamel and dentine of teeth. Streptococcus mutans are 
Gram-positive, facultative anaerobic bacteria with a 
clear association with early dental caries in humans and 
animals. Insoluble glucan, combined by glucosyltrans-
ferase (GTase) in foods with sucrose and produced by S. 
mutans, has a high rate of adhesion to tooth and firm oral 
surfaces, and plays an important role in the development 
of dental caries. Oral microorganisms produce and attach 
glucans to oral surfaces, forming dental plaques and 
producing lactic acid (and others) during carbohydrate 
metabolism [4, 5].
Halitosis, defined as “stink through the mouth or nasal 
cavity” or “unpleasant odor from the mouth”, is caused 
by volatile sulfur compounds (VSCs) such as hydrogen 
sulfide  (H2S) and methyl mercaptan  (CH3SH) [6]. VSCs 
are produced by the decaying action of decomposing epi-
thelial and white blood cells, which are eliminated by oral 
anaerobic bacteria. Volatile sulfur compounds are gener-
ated from sulfur-containing amino acids such as cysteine 
and methionine. Bacterial genera that produce hydrogen 
sulfide from cysteine include Peptostreptococcus, Eubac-
terium, Selenomonas, Centipeda, Bacteroides, Fusobac-
terium, and Prevotella, and genera that make methyl 
mercaptan from methionine are known to include Fuso-
bacterium, Bacteroides, Porphyromonas, and Eubacte-
rium [6, 7]. F. nucleatum, for example, a major hydrogen 
sulfide or methyl mercaptan producing, Gram-negative 
anaerobic bacterium, causes periodontitis and halitosis.
Many studies have been published on the inhibition of 
harmful oral bacteria [8–11]. Antibiotics such as peni-
cillin, erythromycin, and tetracycline are effective in the 
prevention of oral disease, but they have not been uti-
lized due to the overall increase in antibiotic resistance 
by bacteria [12]. Other studies have sought to inhibit oral 
periodontal bacteria using natural materials [11, 13, 14], 
inhibit GTase activity involving sucrose glucan forma-
tion [15], or use sucrose-alternative sweeteners that S. 
mutans is unable to metabolize [16]. Zinc ions, chlorhex-
idine (CHX) and cetylpyridinium chloride (CPC) and 
metal salts have been found to be effective in inhibiting 
the growth of halitosis-causing bacteria or in reducing 
the production of volatile sulfur compounds. Addition-
ally, zinc chloride has been shown to mitigate halitosis by 
eliminating oral anaerobic bacteria [17]. Chlorhexidine, 
which is frequently used as a disinfectant in dental clin-
ics, kills bacteria when applied to tooth enamel or the 
salivary pellicle and is widely used as a disinfectant in 
patients with periodontitis and to minimize halitosis [18]. 
Unfortunately, these strategies are not specific to harm-
ful oral microorganisms or have a short period of action, 
making lasting effects difficult to achieve [19].
Microorganisms present in the oral cavity suppress 
the growth of fungi such as Candida, pathogenic micro-
organisms such as purulent bacteria, and viruses [20]. 
Therefore, a prevention strategy which suppresses the 
growth of all microorganisms present in the oral cav-
ity is inappropriate for the prevention of oral disease. 
A healthy oral cavity can be maintained by promoting 
advantageous bacteria in the oral cavity and inhibiting 
bacteria that cause oral disease [21].
The Korean Ministry of Food and Drug Health requires 
manufacturers to submit information on the sources 
of microorganisms used in foods and drugs to allow for 
food product authorization and regulatory review for 
pharmaceutics. It has also developed a standard frame-
work for quality assurance of these goods. The Korean 
National Institute of Food and Drug Safety Evaluation 
has also laid out standard guidelines for the quality assur-
ance of probiotics products [23]. An estimation of the 
safety level of isolated bacteria for novel clinical probiotic 
use is important for the identification and elimination of 
possible clinical pathogens.
In this study, Lactobacillus spp. were evaluated as a 
means of controlling harmful oral microorganisms. Lac-
tobacillus bacteria that inhibit the growth of harmful oral 
bacteria were collected from the saliva and feces of adults 
over 20 years of age. One individual species was isolated 
and identified, and safety tests were carried out follow-
ing Food and Agriculture Organization of the United 
Nations (FAO)/World Health Organization (WHO)-
recommended studies and other published safety tests 
to verify its safety for academic and commercial applica-
tions [24].
Materials and methods
Collection and isolation of lactic acid bacteria
Samples of saliva were taken from 200 adults over 
20  years of age with little or no supragingival plaque, 
enrolled in Seoul National University’s Food Microbio-
logical Research Laboratory (IRB No. 1907/003-018). 
Before brushing and before meals, samples were taken in 
the morning, combined with sterile 70 percent glycerol 
(1:1), and refrigerated until tested. Fecal samples were 
taken from 28 people over 20 years of age recruited from 
the Catholic University of Korea, Seoul St. Mary’s Hos-
pital (IRB KC17TNSI0570). Feces was collected in stool 
containers and stored frozen until analyzed. Lactobacil-
lus colonies with excellent hydrogen peroxide production 
were selected using the process defined by Eschenbach 
et  al. [25] and John F. T. Spencer [26]. In keeping with 
their methods, two solutions, A and B, were prepared to 
add tetra methyl benzidine (3.3′, 5.5′-tetra methyl benzi-
dine or TMB) agar as a screening agent. Solution A con-
sisted of 3  mL of DMSO (dimethyl sulfoxide, Sigma, St 
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Louis, MO, USA) and 12.5 mg of TMB (Sigma, St Louis, 
MO). Solution B (0.5  mg/mL or 100 U/mL peroxidase) 
consisted of 1 mL of sterilized water and 0.5 mg of per-
oxidase (Sigma, St Louis, MO, USA). de Man-Rogosa-
Sharpe (MRS, BD Difco™, Franklin Lakes, NJ, USA) agar 
was sterilized at 121 ℃ for 15  min and brought to 45 
℃. To create the final selective agar medium, 0.6 mL of 
Solution A and 0.2 mL of Solution B per 10 mL of MRS 
agar was added. The mixture was poured and allowed to 
solidify on plates. Each selection plate, therefore, had a 
concentration of 1 mM TMB and 10 μg/mL (2 U/mL) of 
peroxidase.
To isolate lactic acid bacteria producing hydrogen 
peroxide, 100 μL or μg of each obtained sample was 
diluted serially with sterilized phosphate buffered saline 
(PBS, pH 7.4). The diluted solution was then distrib-
uted across the TMB selective agar plates. After 48 h of 
anaerobic incubation at 37 °C, the samples were exposed 
to 15–30 min of oxygen to allow for indicator response. 
Horseradish peroxidase induces oxidation of TMB by 
bacteria via the production of hydrogen peroxide, form-
ing a blue colony. If the colony was blue, it was assessed 
as producing hydrogen peroxide ( +). Ten single colonies 
of blue color formed on each medium were randomly 
chosen for multiple streaking onto new TMB agar plates 
to separate 500 single colonies.
Challenge and control bacterial strains and growth 
conditions
Four oral anaerobic bacteria (Fusobacterium nucleatum 
KCOM 1001, Porphyromonas gingivalis KCOM 2796, 
Prevotella intermedia KCOM 2889, and Porphyromonas 
catoniae KCOM3169) and seven oral facultative anaero-
bic bacteria (Streptococcus sobrinus KCOM1157, Strep-
tococcus mitis KCOM 1356, Streptococcus oralis KCOM 
1493, Streptococcus gordonii KCOM 1788, Streptococ-
cus sanguinis KCOM 2167, Streptococcus parasanguinis 
KCOM 2522, and Streptococcus mutans KCTC3065) 
from the Korean Collections of Oral Microbiology were 
utilized as challenge strains. F. nucleatum, P. gingivalis, 
P. intermedia, and P. catoniae KCOM3169 were indi-
vidually incubated in KCOM broth (Brain Heart Infu-
sion (BHI, BD Difco™, Franklin Lakes, NJ, USA) with 
0.5% yeast extract (BD Difco™, Franklin Lakes, NJ, USA), 
0.05% Cysteine HCl-H2O (Sigma, St Louis, MO, USA), 
0.025% Resazurin (Sigma, St Louis, MO, USA), 5 mg/mL 
Hemin solution (Sigma, St Louis, MO, USA), and 10 mg/
mL vitamin K1 solution (Sigma, St Louis, MO, USA) for 
24  h at 37  °C under anaerobic conditions (85%  N2, 10% 
 H2, 5%  CO2). S. sobrinus KCOM1157, S. mitis KCOM 
1356, S. oralis KCOM 1493, S. gordonii KCOM 1788, S. 
sanguinis KCOM 2167, S. parasanguinis KCOM 2522, 
and S. mutans KCTC3065 were individually grown in 
BHI broth under aerobic conditions for 24  h at 37 ℃ 
before use. Prior to use in each experiment, strains were 
subcultured twice in the appropriate medium. Weissella 
cibaria, a commercially available oral probiotic used as 
a Lactobacillus control in this study, was inoculated into 
MRS broth and incubated at 37° C for 24 h before use.
Evaluation of the antibacterial effect of isolated lactic acid 
bacteria
Fifty hydrogen peroxide producing Lactobacillus isolates 
were individually incubated at 37 °C in 5 ml of traditional 
MRS broth for 24 h, and their supernatants were recov-
ered by centrifugation at 4  °C for 5  min at 25,000 × g. 
To remove the antimicrobial influence of organic acids, 
the supernatants were adjusted to pH 6.5 ~ 7 with 
1  M syringe sterilized (0.45  μm) NaOH and stored at 
− 20 °C before analysis. Two hundred μL of MRS broth 
was added to 96-well plates (SPL Life Sciences Co., Ltd. 
Pocheon, Korea) and the 11 oral microorganisms were 
inoculated at 1% into each well. Ten μL of each hydro-
gen peroxide producing Lactobacillus isolate supernatant 
was added to the wells seeded with oral microorganisms 
(final concentration 5%) and the plates were anaerobi-
cally incubated at 37  °C. The wells were read at 600 nm 
for up to 24 h using a microplate reader (Epoch2, BioTek, 
Winooski, VT, USA) to determine the level of inhibition 
by the supernantant. One Lactobacillus isolate was desig-
nated as "HHuMIN D" based on its superior inhibition of 
oral microorganism growth. 16S rRNA sequencing was 
conducted to genetically identify the isolated bacteria, 
followed by base-sequence molecular phylogenetic analy-
sis. The organism was identified as L. gasseri and named 
"L. gasseri HHuMIN D". For further experimental use, L. 
gasseri HHuMIN D was inoculated into MRS broth and 
incubated at 37° C for 24 h. The culture broth of L. gasseri 
HHuMIN D was placed in 50% (v/v) glycerol solution and 
stored at − 80 °C.
Evaluation of the effect of L. gasseri HHuMIN D on oral 
microorganisms
To test the impact of L. gasseri HHuMIN D on oral 
microorganisms, viable cell counts were carried out after 
co-culture using selective agar plates. The 11 challenge 
oral bacteria and L. gasseri HHuMIN D were inoculated 
at 5% in a 50% KCOM broth/50% BHI broth medium in 
test tubes. The tubes were incubated at 37 °C for 24 h, fol-
lowed by viable cell counts for each bacterium. All tubes 
were serially diluted after incubation; anaerobes were 
plated on KCOM agar, facultative anaerobes and anaer-
obes were plated on MSB agar (Mitis Salivarius Sucrose 
Bacitracin, Sigma-Aldrich, St. Louis, MO, USA), and 
L. gasseri HHuMIN D was plated on LBS agar (Sigma-
Aldrich, St. Louis, MO, USA). This experiment was 
Page 4 of 24Mann et al. Microb Cell Fact           (2021) 20:75 
repeated three times, and the average value was deter-
mined after calculating the inhibition rate for each rep-
lication as % inhibition = 100 × (MAX—MIN) / MAX 
(where MAX = viable cell count with no inhibition and 
MIN = viable cell count after co-culture).
Hydrogen peroxide production test
L. gasseri HHuMIN D culture medium, prepared as pre-
viously described, was centrifuged for 10 min at 4° C at 
2000 × g, and the supernatant extracted. Supernatants 
were colorimetrically analyzed using Pierce Quantita-
tive Peroxide Assay Kits (aqueous-compatible formula-
tion, Thermo Fisher Scientific, Waltham, MA, USA). 
Two hundred μL of working reagent (containing ammo-
nium ferrous (II) sulfate, sorbitol, xylenol orange) and 
20 μL of L. gasseri HHuMIN D supernatant were placed 
into individual cells of a 96-well microplate and allowed 
to develop for fifteen minutes. A 1 mM (1000 µM) solu-
tion of hydrogen peroxide was produced to standard-
ize hydrogen peroxide production by diluting a 30% 
 H2O2 supply 1:9000 (11µL of 30%  H2O2 into 100 mL of 
ultrapure water). The 1 mM hydrogen peroxide solution 
was then serially diluted 1:2 with sterile water (100 μL of 
sterile water + 100 μL of 1 mM hydrogen peroxide). Two 
hundred μL of the working reagent was then added to 
20 μL of the diluted  H2O2 standard in microplate wells. 
The absorbance of both the L. gasseri HHuMIN D and 
hydrogen peroxide standard plate wells were assessed via 
microplate reader at 595 nm (Epoch2, BioTek, Winooski, 
VT, USA).
Susceptibility assay of the bacteriocin produced by L. 
gasserie HHuMIN D to hydrolytic enzymes
Proteins, carbohydrates and lipolytic enzymes were 
purchased from Sigma Aldrich (St. Louis, MO, USA) 
and used according to the manufacturer’s instructions. 
Lipase (4307 U/mg) and trypsin (13,50 U/mg) in 50 mM 
Tris–HCl buffer (pH 7.5), α-chymotrypsin (83.9 U/mg) 
and carboxypeptidase A (73 U/mg) in 50 mM Tris–HCl 
(pH 8.0), pepsin (3.280 U/mg) in 10  mM citrate (pH 
6.0), α-amylase (519 U/mg) in 0.1  M sodium phosphate 
(pH 7.0) and proteinase K (30 U) /mg) in 0.01  M Tris–
HCl (pH 7.9), 0.05  M EDTA and 0.5% SDS buffer were 
prepared at a concentration of 20 mg/mL. The enzymes 
were added to the culture supernatant at 10% (2 mg/mL) 
and reacted at 37 ℃ for 150 min except for proteinase K, 
which was reacted at 45 ℃ for 12 h. The remaining bac-
teriocin activity was measured using a microtiter plate 
for oral harmful bacteria. A sample not treated with an 
enzyme solution under the same conditions was used as a 
negative control [27].
Coaggregation assays
L. gasseri HHuMIN D coaggregation was tested using the 
challenge microorganisms and a modified Handley et al. 
[28] spectrophotometric assay. L. gasseri HHuMIN D 
cells were harvested by centrifuging the culture medium 
at 4000 × g for 15 min. Pellets were washed with Cisar’s 
buffer three times and resuspended to approximately  109 
cells/mL. One ml of the coaggregation pairs were vor-
texed for 10 s and incubated with soft stirring at 110 rpm 
at 37  °C for 30  min. The coaggregations were then 
allowed to remain at room temperature for 3  min after 
incubation. One half ml of supernatant was removed 
from the culture and the optical density at 660  nm was 
determined using a microplate reader (Epoch2, BioTek, 
Winooski, VT, USA).
Coaggregation was determined using the decrease in 
absorbance vs. the control. The proportion of coaggrega-
tion was determined using the equation by Handley et al. 
(1987):
where X control and Y control represent  OD660 of the 
two microorganisms in the control tubes and (X + Y) is 
the mixture of organisms.
Effect of L. gasseri HHuMIN D on the formation of artificial 
dental plaque by S. mutans
To assess whether and the degree to which L. gasseri 
HHuMIN D prevents the development of artificial den-
tal plaque by S. mutans, beaker wire tests following the 
protocol of Yu et  al. [29] were conducted. Five percent 
sucrose was added to 40 ml of broth consisting of equiv-
alent quantities of BHI and MRS broth and the pH was 
adjusted to 7.0 by the addition of 0.1  M MOPS buffer. 
The medium was inoculated with 1 ×  108 S. mutans and 
1 ×  108 L. gasseri HHuMIN D cells alone or combination. 
Stainless steel orthodontic wires (4  cm length, 0.016-
inch, 1 mm dia, Oramco, Glendora, CA, USA) were sus-
pended on conical tubing and immersed in the broth. 
The weights of the artificial dental plaques produced on 
the wires were calculated after 12 h of incubation at 37° C 
while shaking at 30 rpm.
Coaggregation (%) =
OD660(X control + Y control)/2−OD660(X + Y)× 100
OD660(X control + Y control)/2
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Adhesion assay of L. gasseri HHuMIN D
KB cell line oral epithelial cells (KCLB 10,017) were 
acquired from the Cell Line Bank of Korea (Seoul, Korea). 
KB cells were cultured in RPMI-1640 Media (Sigma-
Aldrich, St. Louis, MO, USA) containing 10% (v/v) fetal 
bovine serum (FBS, Sigma-Aldrich, St. Louis, MO, USA) 
and 1% (v/v) antibiotic–antimycotic solution (Sigma-
Aldrich, St. Louis, MO, USA) in 5%  CO2 at 37 ℃. For the 
adhesion efficiency assay, KB cells were inoculated into 
a minimum critical medium (MEM, Sigma-Aldrich, St. 
Louis, MO, USA) containing 10 percent (v/v) FBS at  1105 
cells/well. Upon transfer to a 24-well multi-culture dish 
(Thermo Fisher Scientific, St Peters, MO, USA), the cells 
were grown for 18 h at 5%  CO2 at 37 °C.
L. gasseri HHuMIN D was grown for 18 h in MRS broth 
at 37 °C and the bacterial concentration was adjusted to 
 108  CFU/mL (measured at 600  nm). Isolated bacteria 
were centrifuged at 8000 × g for 3 min and washed with 
PBS three times. The washed bacteria were then resus-
pended in MEM media. The number of cells measured by 
hemocytometer (Paul Marienfeld, Lauda-Königshofen, 
Germany) was about 6 log cells per well.
L. gasseri HHuMIN D cells were then added to the 
24-well culture dish cells containing KB cells at about 6 
log cells per well and incubated for 1 h at 37 °C and 5% 
 CO2. The suspension was eliminated after incubation and 
the 24-well plates were washed two times with PBS (pH 
7.4). For 10 min, 200 μL trypsin/EDTA (Welgene, Daegu, 
Korea) was applied to the cell monolayer, and the cells 
and attached bacteria were collected. MG cell Genomic 
DNA Extraction SV kits (Doctor Protein, Seoul, Korea) 
were used to remove the genomic DNA (gDNA) of the 
attached bacteria in the extracted pellets. Pending anal-
ysis, the final volume of all DNA samples (200 μL) was 
stored at -20 °C. The number of bacteria adhered to the 
KB cells was determined using qRT-PCR.
Protection and displacement assays were conducted 
to assess the competition between L. gasseri HHuMIN 
D and harmful oral bacteria (F. nucleatum and S. 
mutans) for cell adhesion using modified versions of a 
previously reported process [30]. In protection assays, 
1  mL  (1108  CFU/mL) of L. gasseri HHuMIN D was 
applied to 24-well culture dishes loaded with KB cells 
and incubated for 1 h at 37 °C and 5%  CO2 for 1 h. The 
suspension was removed after incubation, and the cell 
monolayer was washed twice with PBS. Next, 1  mL 
 (1108  CFU/mL) of a harmful oral bacteria suspension 
(F. nucleatum and S. mutans) was applied to the wells 
and incubated for 1 h at 37 °C and 5%  CO2. The suspen-
sion was removed, and the cell monolayer was washed 
twice with PBS. Two hundred μL of trypsin/EDTA 
(Welgene, Daegu, Korea) was added to the KB cell 
monolayer and allowed to stand for 10 min, after which 
the KB cells and attached bacteria were gathered.
In displacement assays, 1  mL  (1108  CFU/mL) of a 
harmful oral bacteria suspension (F. nucleatum and S. 
mutans) was applied to 24-well KB cells and incubated 
for 1  h at 37  °C and 5%  CO2 for 1  h. The suspension 
was removed after incubation and the monolayer cell 
was washed twice with PBS. Next, 1 mL  (1108 CFU/mL) 
of L. gasseri HHuMIN D was applied to the wells and 
incubated for 1 h at 37 °C and 5%  CO2. After the second 
inoculation, the experimental procedure was the same 
as for the protection assays.
KB cells attached only to F. nucleatum and S. 
mutans were used as controls. The number of bacteria 
appended to each KB cell was determined using real-
time PCR.
The collected gDNA was used to quantitatively ana-
lyze each bacterium that was attached to the KB cells 
using real-time PCR. Standard curves were drawn 
using bacterium-specific primers, and the bacteria 
were quantified to test cell adhesion from the extracted 
DNA. A standard curve was drawn using primers spe-
cific to each bacterium, and bacteria were quantified 
from the extracted DNA to measure cell adhesion. 
The primers used to amplify the bacteria are shown 
in Table  1. Real-time PCR was conducted on 96-well 
plates (SPL Life Sciences Co., Ltd. Pocheon, Korea) 
using tepOnePlus™ Real Time PCR systems (Thermo 
Fisher Science, St Peters, MO, USA). The PCR reaction 
was performed using 1 × TB Green™ Premix Ex Taq™ 
(Takara, Japan), and real-time PCR conditions are as 
follows; the first denaturation for 10 min at 95 °C, and 
Table 1 Oligonucleotides used as primers for real-time PCR
Bacteria name Oligonucleotide sequence Length Reference
Lactobacillus Forward TGG AAA CAG RTG CTA ATA CCG 21 [102]
Reverse GTC CAT TGT GGA AGA TTC CC 20
Fusobacterium nucleatum Forward AGA GTT TGA TCC TGG CTC AG 20 [103]
Reverse GTC ATC GTG CAC ACA GAA TTG CTG 24
Streptococcus mutans Forward CTA CAC TTT CGG GTG GCT TG 20 [104]
Reverse GAA GCT TTT CAC CAT TAG AAG CTG 24
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then 40 polymerase chain reaction cycles at 95  °C for 
15 s and 60 °C for 1 min. Analysis of the results was car-
ried out using StepOne ™ and StepOnePlus ™ Software 
v2.3 (Thermo Fisher Scientific, St Peters, MO, USA). 
The number of bacteria was calculated by converting 
the value of the cycle threshold (CT) into the standard 
curve.
Safety assessment of L. gasseri HHuMIN D
Ammonia production testing
The catalyzed indophenol reaction [31] ammonia pro-
duction test was utilized. L. gasseri HHuMIN D cells 
were cultured anaerobically in BHI media at 37  °C for 
5 days, after which the culture medium was centrifuged 
(2236R centrifuge; Labogene Aps, Lillerød, Denmark) 
at 10,000 × g for 30  min to isolate the supernatant. The 
supernatant was adjusted after extraction to pH 7.0.
Two solutions were prepared: Solution A consisted of 
0.01 g of sodium nitroferricyanide dihydrate (Sigma, St. 
Louis, MO, USA) and 2  g of phenol (Sigma, St. Louis, 
MO, USA) in 200  mL LC–MS grade water, and Solu-
tion B consisted of 1 g of sodium hydroxide and 0.08 g of 
sodium hypochlorite in 200 mL LC–MS grade water. One 
hundred μL of L. gasseri HHuMIN D supernatant was 
dispensed into 96-well plates, followed by 10 μL each of 
solutions A and B, and incubated for 1 h at 20 °C. Using 
a microplate reader (Bio-Rad Laboratories, Philadelphia, 
PA, USA) the optical density was measured at 625  nm. 
Uninoculated BHI medium was used as a control and a 
standard curve was used to measure ammonia concen-
tration. Enterococcus faecium ATCC19433 supernatant 
was employed as a positive control.
Biogenic amine production testing
Biogenic amine analysis was conducted using the method 
of Kim et  al. [32]. Four biogenic amines, cadaverine (≧ 
97.0%), histamine (≧ 97.0%), putrescine (≧ 98.5%), and 
tyramine (≧ 99.0%), were purchased from Sigma-Aldrich 
(St. Louis, MO, USA), as were 1.7-diaminoheptane 
(internal standard; ISTD, 98%, Cat. # D174708), dansyl 
chloride (≥ 99.0%, Cat. # 39,220), and L-proline (≥ 99.0%, 
Cat. # P0380). Whatman No. 4 filter paper was purchased 
from Whatman Intl., Ltd (Maidstone, UK). Sodium car-
bonate (99.0%, Cat. # 433,401,201), ether (99.0%, Cat. # 
33475S1280), and acetone (99.7%, Cat. # A0108) were 
purchased from Samchun Pure Chemical Co., Ltd. (Pyeo-
ngtaek, Korea).
L. gasseri HHuMIN D was grown anaerobically in MRS 
broth with 0.05 percent (w/w) L-cysteine-HCl (Sigma, 
St. Louis, MO, USA) at 37 ℃ for 18 h. Next, 25 mL 0.1 N 
HCl was added to 5 mL of L. gasseri HHuMIN D super-
natant and blended for 5  min. The supernatant was 
separated by centrifugation (2236 R centrifuge; Labogene 
Aps, Lillerød, Denmark) at 10,000 × g for 15  min. The 
gathered supernatant was filtered through a 20–25  μm 
membrane filter (Whatman Int’l., Ltd., Maidstone, UK) 
and 1 mL of filtrate was combined with 0.1 mL of 0.01% 
(w/v) 1.7-diaminoheptane, 0.5  mL of saturated sodium 
carbonate solution, and 1 mL of 1% dansyl chloride. The 
mixture was incubated in a water bath (WBC 1510A; Jeio 
Tech. Co., Ltd., Seoul, Korea) after thorough mixing, with 
light blocked at 45 ℃ for 1 h. By adding 0.5 mL of 10 per-
cent proline and 5 mL diethyl ether at room temperature 
and allowing it to stand for 5 min, the remaining dansyl 
chloride was removed. The supernatant was concentrated 
using a Scanvac Speed Vacuum Concentrator (Labogene 
Aps, Lillerød, Denmark) at 1500 rpm and 20° C until dry 
for high performance liquid chromatography (HPLC) 
analysis. Next, the dry pellets were resuspended in 1 mL 
of acetonitrile (Sigma-Aldrich, St. Louis, MO, US). After 
filtering through a 0.22-μm filter membrane, the resus-
pended sample and standard were analyzed. A Thermo 
Dionex Ultimate 3000 HPLC (Thermo Fisher Scientific, 
St Peters, MO, USA) with a VDSpher C-18 column (4.6 
250 mm, 5 µm) (VDS Optilab Chromatographie Technik 
GmbH, Berlin, Germany) was used to analyze the sam-
ples. The mobile phase was (A) acetonitrile, (B) distilled 
water (0–1  min, A: B = 40: 60; 1–25  min, A: B = 100: 0; 
25—35 min, A: B = 60: 40). The injection volume was 20 
μL, the flow rate was 0.8 mL/min, the column tempera-
ture was 30 ℃ (constant), and the UV detection wave-
length was 250 nm.
Hemolysis testing
Hemolysis testing was conducted according to the 
method of Kim et  al. [32]. Hemolysis was observed by 
anaerobic incubation of L. gasseri HHuMIN D in BL 
agar (BD Difco™, Franklin Lakes, NJ, USA) for 2 days at 
37 °C with 5% sheep blood. As a positive control, Listeria 
ivanovii subsp. ivanovii ATCC 19,119 was incubated 
on the same agar for 2 days under aerobic conditions at 
37  °C. The presence or absence of light visible through 
both sides of the plates indicated hemolysis. Strains 
that did not produce green areas around the colonies 
(α-hemolysis) or did not cause hemolysis in the blood 
plate (γ-hemolysis) were considered nonhemolytic. 
Strains having a clear zone around the colonies were clas-
sified as β-hemolytic bacteria.
Mucin degradation testing
The degradation of mucins was estimated using the 
method of Kim et  al. [32]. Type III porcine stomach 
mucin was purchased from Sigma-Aldrich (St. Louis, 
MO, USA). As a negative control, MRS medium was 
used without a carbon source. Four MRS broths with 
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different carbon sources were prepared: 0.5% (w/v) 
mucin, 1.0% (w/v) mucin, 0.5% (w/v) glucose, and 1% 
(w/v) glucose. Each broth was inoculated with L. gas-
seri HHuMIN D and anaerobically incubated 2 days at 
37 °C. Strain growth was estimated using a microplate 
reader (Bio-Rad Laboratories, Philadelphia, PA, USA) 
at 0, 12, 24, 36, and 48 h by measuring the optical den-
sity at 550 nm. By subtracting the final optical density 
value of each sample from the original optical density 
value, the growth in each broth was determined.
Antimicrobial susceptibility testing
Antibiotic resistance may be present in Lactobacillus 
spp. [33] and since antibiotic resistance can be trans-
mitted via plasmids, the evaluation of antibiotic resist-
ance is an important consideration for their safety 
assessment [34]. L. gasseri HHuMIN D antimicrobial 
susceptibility was estimated using the method of Kim 
et  al. [32]. Twenty-three antimicrobial compounds 
were tested in this experiment: ampicillin sodium salt, 
bacitracin, carbenicillin disodium salt, cephalothin 
sodium salt, chloramphenicol, clindamycin hydrochlo-
ride, dicloxacillin sodium salt hydrate, erythromycin, 
gentamicin sulfate, kanamycin sulfate, lincomycin, 
methicillin, metronidazole, mupirocin, neomycin sul-
fate, penicillin G, phosphomycin disodium salt, poly-
myxin B sulfate salt, rifampicin, streptomycin sulfate 
salt, tetracycline, trimethoprim–sulfamethoxazole (tri-
methoprim), and vancomycin hydrochloride.
All antimicrobials were purchased from Sigma (St. 
Louis, MO, USA) except vancomycin hydrochloride, 
which was purchased from USP, Bethesda, Maryland, 
USA. Before being added to LSM-Cys broth (LAB sus-
ceptibility test medium with L-cysteine, consisting of 
90 percent IST and 10 percent MRS broth medium), 
each antibiotic powder was dissolved in a suitable dil-
uent, sterilized and filtered. IST was purchased from 
Kisan Bio Co., Ltd. (Mb cell I so-Sensitest Broth, Seoul, 
Korea), and MRS was purchased from Becton, Dickin-
son and Company (BD Difco™ MRS Lactobacilli broth, 
Franklin Lakes, NJ, USA). The ISO10932: 2010 mini-
mal inhibitory concentration (MIC) values  for the 20 
antibiotics tested on L. gasseri HHuMIN D were used.
1. For this experiment, LSM-Cys (LAB susceptibil-
ity test) medium containing 0.03% (w/v) L-cysteine 
HCl was used with 96-well plates. Upon diluting 
serially twice, the antibiotic broth used ranged from 
0.0032—1024  g/mL. Finally, the microorganisms 
were inoculated at a rate of 0.2% (the final concentra-
tion was approximately  3108 cfu/mL) in the LSM-Cys 
media and 50 μL of each diluted medium was inocu-
lated into each well. There was no negative control. 
The dilute medium was anaerobically incubated at 
37 °C for 48 h. The MIC was visually determined by 
comparing the test samples to the control; antibiotic 
susceptibility was considered to be the prevention of 
bacterial growth by 80% or more.
Complete genome sequencing, assembly, and annotation 
of L. gasseri HHuMIN D
Chunlab, Inc. (Seoul, Korea), which used PacBio Sequel 
Systems (Pacific Biosciences, Menlo Park, CA, USA) and 
CLgenomicsTM and EZBioCloud Apps services (Chun-
lab, Seoul, Korea), conducted whole genome sequenc-
ing of L. gasseri HHuMIN D. General gene information 
was investigated by EZBiodCloud Apps and functional 
annotations for the expected genes were analyzed using 
RefSeq protein (NR; NCBI), Clusters of Orthologous 
Groups of proteins (COG), EggNOG, SEED, Swiss-Prot, 
and Kyoto Encyclopedia of Genes and Genomes (KEGG) 
databases [35–38].
Safety evaluation with complete genome sequence
Analysis of virulence factors was carried out through the 
VirulenceFinder 2.0 Website, which is a part of the openly 
accessible web-based tool for whole genome sequencing 
(WGS) analysis hosted by the Center for Genomic Epi-
demiology (CGE, http:// www. genom icepi demio logy. org/, 
2014). The predicted L. gasseri HHuMIN D genes were 
compared with the comprehensive antibiotic resistance 
database (CARD, http:// arpca rd. mcmas ter. ca) for iden-
tifying antibiotic resistance (https:// card. mcmas ter. ca). 
The ability to synthesize biogenic amines and aggregate 
platelets was searched using full genome sequencing of 
L. gasseri HHuMIN D via CLGenomics (ChunLab, Seoul, 
South Korea, 2004) through matching with the KEGG 
pathway.
Statistical analysis
Data are expressed as mean ± SEM by SPSS software 
(IBM SPSS Statistics, Version 25, SPSS Inc., Chicago, IL, 
USA). Differences between the means were measured 
by one-way ANOVA using Duncan’s multiple range test. 
Statistical significance was assumed at p < 0.05.
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Results and discussion
Identification of hydrogen peroxide‑generating lactobacilli
The screening of Lactobacillus progressed in a three-step 
process. First, 500 strains with excellent development of 
hydrogen peroxide were isolated from saliva and feces. 
Second, Lactobacillus sp. were collected using LBS agar 
plates to sort through the 500 isolated strains. A total of 
50 isolates were identified. Finally, the 50 isolates were 
tested for their strength against oral microorganisms, 
and HHuMIN D was the most effective.
The antimicrobial effect of 5% of HHuMIN D superna-
tant was clearly demonstrated in the control of anaerobic 
oral bacteria causing halitosis. P. catoniae, P. interme-
dia, F. nucleatum, and P. gingivalis were inhibited by 90, 
89 ± 1, 88 ± 1, and 88 ± 1%, respectively. S. mutans, a 
dental caries-inducing bacterium, was inhibited by 
60 ± 2%. S. mitis and S. gordonii, which cause periodon-
titis, were inhibited by 22 ± 2 and 19 ± 5%, respectively. 
Antimicrobial activity was lower against oral facultative 
anaerobic bacteria (S. sobrinus, S. sanguinis, S. parasan-
guinis, and S. oralis). On the other hand, the antimicro-
bial effect of 5% of W. cibaria culture supernatant showed 
relatively weaker antimicrobial activity than HHuMIN D 
(Table 2).
Lactobacillus culture medium neutralization and dis-
infection is an experimental process used to monitor the 
antibacterial activity of bacteria metabolites, such as bac-
teriocin. In another study, sterile neutral S. mutans ATCC 
25,175 supernatant showed > 80% inhibition of L. paraca-
sei strains [39]. Another study confirmed that Lactobacil-
lus gasseri, which produces gassericin A, has inhibitory 
properties against a wide range of oral pathogens, includ-
ing carcinogenic and periodontal pathogens [40].
HHuMIN D was shown to produce hydrogen perox-
ide and suppress oral microorganisms. 16S rRNA gene 
sequencing of HHuMIN D showed that it is a Lactobacil-
lus sp. Multiple alignment of 16S rRNA base sequences 
of isolated bacteria with the Lactobacillus sp. 16S rRNA 
sequence was obtained through the similarity matrix 
listed on GenBank. This genealogy research showed 
a 99% 16S rRNA homology; HHuMIN D shares 99% 
homology with L. gasseri (Fig. 1).
Lactobacillus species isolated from the oral cavity vary 
widely. Lactic acid bacteria such as L. acidophilus, L. 
casei, L. fermentum, L. gasseri, L. johnsonii, L. rhamno-
sus, L. reuteri, L. salivarius and L. vaginalis are probiotic 
strains commonly used in dairy and health/functional 
food products [41–44]. The current research confirms 
that candidate probiotic Lactobacillus strains are present 
in the oral cavity and the probiotic capabilities of L. gas-
seri HHuMIN D.
Inhibition effect of L. gasseri HHuMIN D on oral 
microorganisms
Oral lactic acid bacteria are known to inhibit harm-
ful oral bacteria by the production of various antibiotics 
[45]. L. gasseri has been studied as an oral probiotic and 
results have shown that it is effective against harmful oral 
bacteria [46, 47].
The interactions between L. gasseri HHuMIN D and 
oral anaerobic and facultative anaerobic bacteria are 
shown in Fig. 2. All harmful oral bacteria were strongly 
inhibited by L. gasseri HHuMIN D, but interaction 
with oral microorganisms also impaired its prolifera-
tion. Compared to single culture, L. gasseri HHuMIN D 
showed poor growth in most co-cultures. Among them, 
Table 2 Inhibition of periodontal bacteria by L. gasseri HHuMIN 
D supernatant
Values are expressed as the mean ± standard deviation. Means not sharing a 
common letter are significantly different groups at p < 0.001 (n = 3)
Strains Inhibition (%)
W. cibaria L. gasseri HHuMIN D
Fusobacterium nucleatum KCOM 1001 5 ±  1a 88 ± 1a
Porphyromonas gingivalis KCOM 2796 11 ±  3a 88 ± 1a
Prevotella intermedia KCOM 2889 13 ±  1a 89 ± 1a
Porphyromonas catoniae KCOM3169 14 ±  2a 90 ± 0a
Streptococcus sobrinus KCOM1157 8 ±  1a 60 ± 2b
Streptococcus mitis KCOM 1356 17 ±  2b 4 ±  4c
Streptococcus oralis KCOM 1493 22 ±  5b 4 ±  6c
Streptococcus gordonii KCOM 1788 0 ±  0c 19 ±  5d
Streptococcus sanguinis KCOM 2167 0 ±  0c 2 ±  3c
Streptococcus parasanguinis KCOM 
2522
12 ±  3a 2 ±  2c
Streptococcus mutans KCTC3065 0 ±  0c 22 ±  2d
Fig. 1 Most likely phylogenetic tree derived from the 16S rRNA sequence of L. gasseri HHuMIN D
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the lowest viable cell counts occurred when L. gasseri 
HHuMIN D was co-cultured with P. intermedia.
A previous study on the co-culture of oral anaerobia 
(F. nucleatum, P. gingivalis) and beneficial oral bacteria 
(Weissella cibaria) showed that F. nucleatum reduced the 
number of viable cells up to 1.5   108 CFU/mL, and P. gin-
givalis reduced the number of viable cells to <  105 CFU/
mL, compared to controls [19]. In this experiment L. gas-
seri HHuMIN D inhibited F. nucleatum more effectively. 
Additionally, L. gasseri HHuMIN D inhibited P. interme-
dia, P. catoniae and seven facultative anaerobic bacteria 
quite effectively.
In another study, Lactobacillus salivarius, Lactobacil-
lus fermentum, and the fermentation broths of these bac-
teria showed a definite inhibitory effect against harmful 
periodontal bacteria. Lactobacillus spp. showed greater 
direct antibacterial effects against harmful oral bacte-
ria than their microbial supernatants. As the number 
of lactic acid bacteria and the concentration of the fer-
mentation broth increased, the antibacterial effect also 
increased [48]. The current research results are similar to 
those of Chen et al. (2012): L. gasseri HHuMIN D’s anti-
bacterial effect was greater than L. gasseri HHuMIN D’s 
supernatant antibacterial effect. This indicates the direct 
inhibition of harmful bacteria by L. gasseri HHuMIN D 
and indirect inhibition by the metabolites it produces 
[21, 43]. L. gasseri HHuMIN D strongly inhibited all 
harmful oral bacteria, but the supernatant of this bacteria 
inhibited only anaerobic oral bacteria and had different 
effects. The combination of these two actions efficiently 
kills pathogenic microorganisms in the oral environment 
[43]. L. gasseri HHuMIN D may, therefore, mitigate oral 
diseases caused by harmful oral bacteria.
Accumulation of hydrogen peroxide by L. gasseri HHuMIN 
D
Oral Lactobacillus spp. produces bacteriocins, lactic 
acid and hydrogen peroxide, which act as a defense 
against pathogens [22, 49]. The generation of hydrogen 
peroxide is a typical function of Lactobacillus spp. (L. 
bulgaricus, L. lactis, and L. plantarum) isolated from 
the oral cavity. Several studies have shown that these 
beneficial bacteria inhibit the growth of pathogenic 
microorganisms such as Staphylococcus aureus [50], 
Pseudomonas spp. [51], and psychrotrophic bacteria 
[52, 53]. The hydrogen peroxide produced by L. gasseri 
HHuMIN D increased continuously from 0  μmol/L 
to 802  μmol/L after 3  h (Fig.  3). After 12  h, the con-
centration of hydrogen peroxide decreased steadily to 
24  h. L. johnsonii and L. gasseri have been shown to 
produce hydrogen peroxide at rates between 400 and 
1400 μmol/L [54]. Other research found that S. sanguis 
released hydrogen peroxide up to 30 μmol/L, S. oralis 
released hydrogen peroxide up to 640 μmol/L and both 
inhibited plaque formation by inhibiting S. mutans 































Fig. 2 Inhibitory effect of L. gasseri HHuMIN D on the proliferation of various periodontal bacteria. ▩, L. gasseri HHuMIN D; □, Periodontal bacteria 
group; ▨, Periodontal bacteria in mixed culture; ■, L. gasseri HHuMIN D in mixed culture. Log 7 and below means <  105
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thiocyanate to oxygen-supplied cultures revealed that 
S. mutans was inhibited, but did not affect the growth 
of, S. sanguis and S. oralis [55]. Additional research 
contends that  H2O2 produced by beneficial bacte-
ria can decrease halitosis by inhibiting the growth of 
F. nucleatum and reducing the VSC produced by oral 
anaerobic bacteria [56].
L. gasseri HHuMIN D was shown to produce good 
amounts of hydrogen peroxide and is predicted to sup-
press harmful anaerobic bacteria that are vulnerable to 
hydrogen peroxide by continuous production. Further 
experimentation will be necessary to specifically investigate 
the effect of L. gasseri HHuMIN D’s  H2O2 on oral anaerobic 
bacteria.
Susceptibility of the bacteriocin produced by L. gasserie 
HHuMIN D to hydrolytic enzymes
Antibacterial activity was completely lost by proteinase 
K, trypsin, and α-chymotrypsin treatment, indicating 
that the antibacterial substance produced by L. gas-
seri HHuMIN D is proteinaceous, and possibly bacte-
riocin (Table 3). The fact that the activity was not lost 
by pepsin treatment is possibly an enzyme concentra-
tion issue or indicative of the lack of a specific cleav-
age site for pepsin to react at. Since α-amylase did not 
affect the antibacterial activity, the carbohydrate moi-
ety was either not present in the antibacterial molecule 
or not related to the antibacterial activity. Bacteriocins 
in which antibacterial activity is lost only with proteo-
lytic enzyme treatment have previously been reported, 
as in the case of Bacillus licheniformis [27]. The great-
est advantage of bacteriocin is that it is composed of 
proteins or peptides and it is decomposed by proteo-
lytic enzymes in the digestive tract of the human body, 
so it is considered to be non-toxic and non-persistent 
[57–60].
Fig. 3 Optical density (●), pH (■) and accumulation of hydrogen peroxide of L. gasseri HHuMIN D (light gray) and W. cibaria (dark gray) cultivated 
in MRS medium (pH6.5) at 37℃ under anaerobic conditions (n = 3)
Table 3 Susceptibility of L. gasserie HHuMIN D culture 
supernatant antimicrobial activity to various hydrolytic enzymes
Fusobacterium nucleatum, Porphyromonas gingivalis, Prevotella intermedia, and 
Porphyromonas catoniae were used as indicators. Degree of growth inhibition by 
OD (600 nm): “+++”, value similar to control; “++”, value weaker than control; 
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Coaggregation of L. gasserie HHuMIN D and oral 
microorganisms
L. gasseri HHuMIN D was shown to have the high-
est cohesion with P. catoniae (70%) and P. interme-
dia (28 ± 5%) and there was no cohesion with P. 
gingivalis or F. nucleatum. Amongst aerobic oral bacteria, 
L. gasseri HHuMIN D coaggregated with S. sanguinis best 
(74 ± 2%), followed by S. gordonii (62 ± 1%), S. mutans 
(49 ± 4%), S. mitis (46 ± 3%), S. sobrinus (37 ± 2%), S. ora-
lis (30 ± 2%), and S. parasanguinis (6 ± 3%). However, 
the coaggregation of W. cibaria was relatively weaker 
than that of L. gasseri HHuMIN D (Table  4). L. gasseri 
HHuMIN D generally has higher coaggregation with oral 
facultative anaerobic bacteria than oral anaerobic bac-
teria with the exception of P. catoniae, which indicates 
that L. gasseri HHuMIN D possesses effective inhibitory 
capacity against oral facultative anaerobic bacteria. In 
another study evaluating the accumulation of 4 strains of 
human streptococci and 6 strains of lactobacillus used in 
consumer products, all probiotic strains showed the abil-
ity to aggregate with oral pathogens, but the degree of 
aggregation was different for each strain and dependent 
on time [61]. This indicates that only some Lactobacillus 
strains can aggregate with harmful bacteria.
Over 500 bacterial species have been identified in the 
oral cavity, of which 15–20 are known to produce toxic 
materials and are directly implicated in the evolution 
of various forms of periodontal disease [62]. Many of 
these harmful bacteria are also highly capable of coagu-
lating with other microorganisms, live in the oral cav-
ity and create toxic substances constantly, thus harming 
oral health [63]. Although the mechanism of aggrega-
tion has not been identified, the ability of probiotics to 
coaggregate with harmful bacteria is important as a sec-
ondary function to support the main function of probiot-
ics. Oral probiotics must adhere well with harmful oral 
bacteria, inhibit their growth, and effectively diminish 
oral disease [64, 65]. Additionally, harmful bacteria are 
exposed directly to antimicrobials such as bacterioc-
ins, lactic acid, and hydrogen peroxide through direct 
coaggregation with beneficial bacteria [66]. L. gasseri 
HHuMIN D’s ability to coaggregate with harmful bac-
teria is therefore an important indicator of its potential 
value as an oral probiotic.
Table 4 Coaggregation reactions between W. cibaria or L. 
gasseri HHuMIN D and various periodontal bacteria
Values are expressed as the mean ± standard deviation. Means not sharing a 
common letter are significantly different groups at p < 0.001 (n = 3)
Strains Coaggregation (%)
W. cibaria L. gasseri HHuMIN D
Fusobacterium nucleatum KCOM 1001 4 ±  2a 2 ±  2a
Porphyromonas gingivalis KCOM 2796 0 ±  1a 0a
Prevotella intermedia KCOM 2889 0 ±  2a 28 ±  5b
Porphyromonas catoniae KCOM3169 0 ±  1a 70 ±  0c
Streptococcus sobrinus KCOM1157 20 ±  1b 37 ±  2b
Streptococcus mitis KCOM 1356 2 ±  0a 46 ±  3d
Streptococcus oralis KCOM 1493 0 ±  1a 30 ±  2b
Streptococcus gordonii KCOM 1788 11 ±  6b 62 ±  1c
Streptococcus sanguinis KCOM 2167 50 ±  3c 74 ±  2e
Streptococcus parasanguinis KCOM 2522 0 ±  3a 6 ±  3a
Streptococcus mutans KCTC3065 29 ±  4d 49 ±  4d
Fig. 4 Effect of L. gasseri HHuMIN D on the formation of artificial 
plaque by S. mutans on wires using BHI media containing 5% sucrose. 
Artificial plaque formed on wires in S. mutans single culture (a), L. 
gasseri HHuMIN D single culture (b) and L. gasseri HHuMIN D / S. 
mutans co-culture culture (c) are shown
Table 5 Effect of L. gasseri HHuMIN D on the formation of 
artificial plaque by Streptococcus mutans on wires using BHI 
media containing 5% sucrose
The values are expressed as the mean ± standard deviation. Means not sharing a 
common letter are significantly different groups at p < 0.001 (n = 3)
Tested bacterial strain Plaque weight (mg)
S. mutans 105 ±  5a
W. cibaria 0 ±  0b
L. gasseri HHuMIN D 0 ±  0b
W. cibaria + S. mutans 53.4 ±  12c
L. gasseri HHuMIN D + S. mutans 0 ±  0b
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Effect of L. gasseri HHuMIN D on the formation of artificial 
dental plaque by S. mutans
Artificial dental plaques formed on calibration wire sus-
pended in S. mutans inoculated broths, but such plaques 
were not developed in L. gasseri HHuMIN D and W. 
cibaria inoculated broths. No artificial dental plaque was 
formed on calibration wire in broth co-cultured with S. 
mutans and L. gasseri HHuMIN D, indicating 100% inhi-
bition (Fig. 4; Table 5).
In one study, S. mutans created artificial dental plaque 
was suppressed by 53% by E. faecium T7 co-culture [29]. 
In another experiment, Lactobacillus lactis 1370 sup-
pressed plaque formation by 95% [67]. Compared to 
other organisms tested, L. gasseri HHuMIN D strongly 
inhibits dental plaque formation by S. mutans.
Adhesion of L. gasseri HHuMIN D
Oral epithelial cell monolayer testing is a method used 
to identify beneficial bacteria and has also been used as 
a guide to test the attachment of beneficial bacteria to 
the oral epithelium. According to an earlier study, if the 
number of attached bacteria per KB cell is 1.5 or more, 
the attachment capacity is considered to be very strong 
and if the number of attached bacteria is 1.5 to 1, the 
adhesion capacity is considered to be strong. If the num-
ber of bacteria attached is 1 to 0.5, the ability to adhere 
is moderate and if the number of the bacteria attached is 
less than 0.5, the ability to adhere is considered weak [68]. 
The KB cell adhesion ability of L. gasseri HHuMIN D was 
determined to be 4.41 ± 1.4 cells per cell– very strong. 
F. nucleatum showed a very high adhesion capacity of 
18.35 ± 4.0, and S. mutans showed a strong adhesion 
capacity of 2.57 ± 0.1 (Table 6). Strains with strong adhe-
sion are likely to adhere to oral epithelial cells, form colo-
nies, and inhibit the attachment of pathogenic bacteria to 
epithelial cells. In a previous analysis, the adhesion abili-
ties of harmful bacteria were measured for P. intermedia 
from 4.1104 ± 2.7104 to 152 ± 57 per  105  KB cells, for P. 
gingivalis at 9.6105 ± 1.0105, and for E. coli at 278 ± 133 
[68]. In another study, F. nucleatum’s KB cell adhesion at 
the initial dose was from 19.2 ± 0.3% to 1.5 ± 0.4, suggest-
ing that F. nucleatum has very strong adhesion capabili-
ties [69].
The ability of L. gasseri HHuMIN D to inhibit cell 
adhesion by harmful bacteria was assessed by conduct-
ing protection and displacement assays. In the protection 
assays, L. gasseri HHuMIN D was allowed to bind to KB 
cells before introducing harmful oral bacteria. L. gasseri 
HHuMIN D reduced the adhesion of F. nucleatum and S. 
mutans to cells by 100% and 90%, respectively. Unfortu-
nately, L. gasseri HHuMIN D’s cell adhesion was reduced 
by 63% and 71%, respectively, by competition with F. 
Table 6 Adhesion ability to KB cells of tested strains
The values are expressed as the mean ± standard deviation for triplicate samples 
of lysates from the infection of  105 KB cells by  108 bacteria. Means not sharing a 
common letter are significantly different groups at p < 0.01 (n = 3)
Strains No. of CFU recovered
L. gasseri HHuMIN D 4.41 ± 1.4a
F. nucleatum KCOM1001 18.35 ± 4.0b
S. mutans KCTC3065 2.57 ± 0.1a
Table 7 The number of experimental bacteria and pathogens bound to KB cells in adhesion ability, protection assays and 
displacement assays
a Values represent the means ± the standard deviations for triplicate samples of lysates from the infection of  105 KB cells by  108 bacteria. Compared with the positive 
control group: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (n = 3)
b Protection assays are a method of investigating how harmful bacteria are inhibited from attaching by selected bacteria which are already attached
c Displacement assays are a method of investigating the degree of attachment by selected bacteria after harmful bacteria are already attached
Strains No. of CFU recovered 




Positive Control L. gasseri HHuMIN D 4.41 ± 1.4
F. nucleatum KCOM1001 18.35 ± 4.0
S. mutans KCTC3065 2.57 ± 0.1
Protection  assaysb (L. gasseri HHuMIN D → F. nucleatum KCOM1001) L. gasseri HHuMIN D 1.64 ± 0.2** 63
(L. gasseri HHuMIN D → F. nucleatum KCOM1001) F. nucleatum KCOM1001 0.05 ± 0.0*** 100
(L. gasseri HHuMIN D → S. mutans KCTC3065) L. gasseri HHuMIN D 1.27 ± 0.6** 71
(L. gasseri HHuMIN D → S. mutans KCTC3065) S. mutans KCTC3065 0.25 ± 0.2**** 90
Displacement  assaysc (F. nucleatum KCOM1001 → L. gasseri HHuMIN D) L. gasseri HHuMIN D 1.32 ± 0.4** 70
(F. nucleatum KCOM1001 → L. gasseri HHuMIN D) F. nucleatum KCOM1001 2.10 ± 0.8*** 89
(S. mutans KCTC3065 → L. gasseri HHuMIN D) L. gasseri HHuMIN D 1.18 ± 0.3** 73
(S. mutans KCTC3065 → L. gasseri HHuMIN D) S. mutans KCTC3065 0.27 ± 0.1**** 90
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nucleatum and S. mutans. L. gasseri HHuMIN D strongly 
inhibited F. nucleatum adhesion and it appears that the 
cell adhesion of L. gasseri HHuMIN D might also have 
been reduced by competition with harmful oral bacteria 
(Table 7).
The attachment of L. gasseri HHuMIN D after the 
attachment of harmful oral bacteria was measured in dis-
placement assays. With F. nucleatum and S. mutans, the 
cell adhesion of L. gasseri HHuMIN D decreased to 70 
and 73%, respectively. However, the attachment of harm-
ful oral bacteria decreased by 89 and 90%, respectively. 
Taken together, these two results indicate a stronger abil-
ity to inhibit the binding of harmful bacteria when first 
bound to L. gasseri HHuMIN D. This suggests that L. 
gasseri HHuMIN D is more effective in preventing than 
inhibiting the attachment of harmful oral bacteria. Con-
sequently, continuous intake is likely necessary to enable 
adhesion of L. gasseri HHuMIN D to highly concentrated 
oral cavity cells. Other researchers have theorized there 
is competition for common adhesion receptors between 
harmful bacteria and beneficial oral bacteria [70] and that 
antibacterial or antiadhesive factors produced by benefi-
cial bacteria inhibit harmful oral bacteria from adhering 
after beneficial bacteria aggregate [71].
Safety evaluations of L. gasseri HHuMIN D
Microorganisms may create various poisonous sub-
stances by nitrogen derivatives through protein, pep-
tide and amino acid decomposition in saliva or food 
[73]. When a microorganism enters the large intestine, 
it is able to generate poisonous substances such as phe-
nol, ammonia and indole by decomposition of proteins 
[72]. Ammonia formed by microorganisms is known to 
migrate to the liver and cause cell damage cofactors and 
chronic hepatic damage. The production of ammonia 
from microorganisms is closely related to human health 
and must be assessed to demonstrate the safety of com-
mercial probiotics. According to Vince and Burridge 
[73], Clostridia, Enterobacter, Bacillus spp., and Gram-
negative anaerobes create large amounts of ammonia. 
Furthermore, certain Streptococci, Micrococci, and Gram-
positive non-spore forming anaerobes release small 
quantities of ammonia, and Gram-positive aerobic rods 
generate trace amounts of ammonia. Certain strains of 
Lactobacillus can produce small amounts of ammonia 
during growth. The evaluation of ammonia production 
confirmed the safety of L. gasseri HHuMIN D; it pro-
duced no ammonia. In contrast, Enterococcus faecium 
ATCC19433, a positive control, produced 109 ± 7 μg/mL 
of ammonia. L. gasseri HHuMIN D’s ammonia produc-
tion is below the level of concern in South Korea’s Min-
istry of Food and Drug Safety’s milk product quality [23].
Biogenic amines (BAs) derived from amino acids are 
common anti-nutritional compounds in animals and 
humans. Ingestion of massive amounts of BAs may cause 
symptoms similar to significant allergic reactions. BAs 
have been identified as causative agents in many cases 
of food poisoning and are critical from a hygienic point 
of view because they can induce a variety of pharma-
cological reactions [74]. BAs are involved in numerous 
mammalian metabolic and intracellular processes, such 
as synaptic transmission, modulation of blood pressure, 
allergic reactions, and management of cellular growth. 
Probiotic bacteria, commonly used in the food industry, 
produce BAs through microbial metabolic activities such 
as decarboxylation and protein molecule transamination 
[75]. L. gasseri HHuMIN D did not produce cadaver-
ine, histamine, putrescine, or tyramine. Since ammonia 
and/or BAs are used as a quality indicator for fermented 
foods, L. gasseri HHuMIN D’s absence of ammonia and 
BA activity suggests that L. gasseri HHuMIN D is suit-
able for use in the manufacture of fermented and non-
fermented foods.
The Guidelines for the Evaluation of Probiotics in Food, 
produced by FAO and WHO joint research, states, “If the 
strain under evaluation belongs to a species with known 
hemolytic potential, determination of hemolytic activ-
ity is required” [24, 76]. The hemolytic characteristics 
of microorganisms are an important measurement cri-
terion for the safety of bacteria since they may liquefy/
degrade red blood cells and ultimately cause anemia and 
edema. Among probiotics, Lactobacillus spp. are graded 
as α-hemolytic microorganisms [77]. However, several 
Lactobacillus spp. (L. sakei MBSa1 bac + , L. curvatus 
MBSa3 bac + and L. lactis 368 bac–) demonstrate strong 
β-hemolysis [78]. L. ivanovii developed β-hemolysis 
colorless zones around colonies in BL agar added 5% 
sheep blood but L. gasseri HHuMIN D cultivated in the 
same medium did not reveal colorless zones around the 
colonies (Fig.  5). Therefore, L. gasseri HHuMIN D does 
not cause hemolysis.
While there is no need for a safety assessment for 
mucin deterioration in the oral cavity, this study was per-
formed to take into consideration the potential for inges-
tion and entry to the intestine by L. gasseri HHuMIN D. 
L. gasseri HHuMIN D was also assessed for the poten-
tial of translocation by in  vitro mucolytic assays. Sev-
eral research teams have studied the mucous dissolving 
capacities of human pathogenic bacteria since 1980, 
and that is now considered a measure of microbial vir-
ulence and microbial toxicity [79–82]. The intestinal 
mucus gel coating is a membrane made of glycoproteins 
and is an essential part of the intestine. Bacterial trans-
location is considered one of the most critical probiotic 
safety tests due to the risk for septicemia and bacteremia 
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endocarditis [83]. Although most microorganisms do not 
exhibit mucolytic activity, several studies have reported 
that certain microorganisms do and the genes that induce 
mucin degradation enzymes have been identified [84]. 
Various intestinal pathogens are known to hydrolyze gly-
coprotein-based mucus gel layers and possess the ability 
to metabolize mucus-derived monosaccharides [85].
If L. gasseri HHuMIN D had the ability to produce 
mucinases, through mucin degradation it would be 
able to survive and grow aggressively in the presence of 
mucin and no other carbohydrate sources. As illustrated 
in Fig.  6, L. gasseri HHuMIN D growth was actively 
induced by the addition of glucose as the carbon source. 
But growth was not observed when glucose was replace 
by mucin. These results show that L. gasseri HHuMIN D 
does not use mucin as a carbon source for growth.
To distinguish antibiotic tolerance from antibiotic-sen-
sitivity, microbiological cut-off values for the antibiotic 
Fig. 5 Hemolysis activity of L. ivanovii subsp. ivanovii ATCC 19,119 (a); positive control, back light) (beta hemolytic) and L. gasseri HHuMIN D (b); 
back light). Purified culture strains were streaked on 5% blood agar plate. After 24 h, the changes of plate color were observed. L. gasseri HHuMIN D 






















Fig. 6 The effect of different concentrations (0, 0.5 and 1% [w/v]) of mucin and dextrose on L. gasseri HHuMIN D in modified MRS, evaluated by 
optical density (550 nm) and recorded after 3 to 21 h (n = 3)
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tolerance of microorganisms used as food were defined 
by the European Food Safety Authority [86]. In a study of 
Lactobacillus spp.’s susceptibility to 23 antibiotics, some 
lactobacilli showed resistance to kanamycin, vancomy-
cin, and chloramphenicol. The authors hypothesized 
that strains with these genes did not necessarily indi-
cate cause for concern about the transition of antibiotic 
resistance and could be used in food and medicinal for-
mulations as natural biopreservatives [87]. Ampicillin, 
erythromycin, vancomycin, chloramphenicol, and clin-
damycin were low compared to the cut-off values pro-
posed by EFSA. Antibiotic resistance can be transmitted 
via plasmids, the assessment of antibiotic resistance is a 
significant criterion for assessing Lactobacillus sp. safety 
[88]. Therefore, we used WGS to genetically identify the 
antibiotic resistance gene of L. gasseri HHuMIN D and 
ascertain the possibility of transmission to other bacte-
ria through the presence or absence of a plasmid. Except 
for gentamicin, streptomycin, and kanamycin, the MIC 
values of L. gasseri HHuMIN D were less than or equal 
to the cut-off values proposed by the EFSA. As shown in 
Table 8, L. gasseri HHuMIN D was sensitive to ampicillin, 
carbenicllin, cephalothin, chloramphenicol, clindamycin, 
dicloxacillin sodium salt hydrate, erythromycin, linco-
mycin, methicillin, penicillin G, tetracycline, and vanco-
mycin (MICs ranged from 0.01 to 4  µg/mL). There was 
general resistance to bacitracin, gentamicin, katamycin, 
metronidazole, neomycin, polymyxin B, phosphomycin, 
streptomycin, and trimethoprim-Sulfamethoxazole (all 
MICs were greater than 32 µg/mL).
Table 8 Antimicrobial susceptibility (MIC values) of L. gasseri HHuMIN D
n.r. not required.
a Data from EFSA (2012)
b including L. delbrueckii, L. helveticus, L. gasseri
c including L. fermentum
d not required for L. salivarius
Classification Antimicrobial agent (MIC values, µg/mL)





L. gasseri HHuMIN D E. faecium 
ATCC 
29,212
β-Lactam group Penicillin G 0.063 0.5
Carbenicllin (disodium salt) 0.5 8
Methicillin 2 16
Ampicillin (sodium salt) 1 2 0.25 0.25
Dicloxacillin sodium salt hydrate 0.5 4
Aminoglycoside group Gentamicin (sulfate) 16 16 32 256
Streptomycin (sulfate salt) 16 64 64  > 256
Kanamycin (sulfate) 16 32 512 256
Neomycin (sulfate) 256 1024
Cephem group Cephalothin (sodium salt) 1 16
Tetracycline group Tetracycline 4 4 4 32
Peptide group Polymyxin B (sulfate salt)  > 1024  > 1024
Bacitracin 64
Macrolide group Erythromycin 1 1 0.5 8
Synthetic antimicrobial group Metronidazole  > 256  > 256
The other group Vancomycin (HCl) 2d n.r 0.5 2
Chloramphenicol 4 4 2 8
Lincomycin (hydrochloride) 4
Rifampicin  < 0.125 0.5
Clindamycin (hydrochloride) 1 1 0.5  > 16




 > 256 32
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Whole genome sequencing (WGS) is a technique 
which studies the functional aspects of a microorgan-
ism by sequencing a microorganism’s entire genome 
and comparing it to a gene previously identified [89]. 
The size of the entire gene sequence of L. gasseri 
HHuMIN D was 2,066,663  bp and the GC composi-
tion ratio was 34.9%. The average GC content of Lacto-
bacillus spp. is 46.61%, L. gasseri HHuMIN D is lower 
than the average GC content of Lactobacillus spp. The 
number of rRNA genes and tRNA genes were 7 and 63, 
respectively. The number of coding sequences (CDSs) 
was 2,015, and the average of the coding sequence 
length was 923.9  bp. Figures  7 and 8 show a genetic 
map of L. gasseri HHuMIN D and a functional classifi-
cation based on COG.
Bacteriocin is a proteinaceous bacterial product with 
bactericidal activity [90]. Any Gram-positive bacte-
ria that produce bacteriocin are considered to be active 
against Gram-negative bacteria [91]. This broad spec-
trum of compounds is important in preventing the 
growth of harmful bacteria and alleviating disease. They 
Fig. 7 Genome map of L. gasseri HHuMIN D. Whole genome sequencing of L. gasseri HHuMIN D was performed by Chunlab, Inc. (Seoul, Korea), 
which used PacBio Sequel Systems (Pacific Biosciences, Menlo Park, CA, USA) and analyzed using CLgenomics™ and EZBioCloud Apps programs 
(Chunlab, Seoul, Korea). The gene content circular image consists of five circles, and each circle shows the information of rRNA/tRNA, Reverse CDS, 
Forward CDS, GC Ratio and GC skew from the outside to the inside
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are produced by specific lactic acid bacteria, including 
lactococci, lactobacilli, and pediococci [92].
Since 1980, the L. acidophilus group has been clas-
sified by DNA-DNA homology into six homologous 
species: L. acidophilus, L. amylovorus, L. crispatus, L. 
gallinarum, L. gasseri and L. johnsonii [93, 94]. Out of 
these six species L. gasseri is thought to be the primary 
member inhabiting the human intestine, and studies 
on the bacteriocins produced by this bacterium have 
been conducted [94–96]. Lactacin F is the best-stud-
ied bacterocin in the LAB class IIb. Gassericin T is a 
2-component bacteriocin consisting of GatA and GatX 
and of the lacticin-F family; it is known as the primary 
bacteriocin developed by L. gasseri strains [97]. Gas-
sericin T is heat-stable (121  °C, 10  min), pH-tolerant 
(pH 2–11) and bactericidal against several food poison-
ing gram-positive bacteria such as Bacillus cereus, Lis-
teria monocytogenes, and Staphylococcus aureus [94]. 
Helveticin J was first studied in L. helveticus. Helveticin 
J can be used as an indicator of closely related species, 
is active at neutral pH under aerobic or anaerobic con-






































Fig. 8 Functional categories based on EggNog/COG of genome of L. gasseri HHuMIN D. Whole genome sequencing of L. gasseri HHuMIN D 
was performed by Chunlab, Inc. (Seoul, Korea), which used PacBio Sequel Systems (Pacific Biosciences, Menlo Park, CA, USA) and analyzed using 
CLgenomics™ and EZBioCloud Apps programs (Chunlab, Seoul, Korea). The function of each protein was found through homology comparison 
with NCBI’s RefSeq Database, and functional categories were completed by synthesizing information such as COG classification by NCBI COG, SEED 
classification by FIGfam, and EC classification etc. The figure is a combination of the assignments of each COG and the functional category (25 
categories, which are often designated from A to Z) using EggNog
Table 9 Genes and genetic characteristics of L. gasseri HHuMIN D bacteriocin on the basis of whole genome sequencing results
Gene Length Product Database hit Homology
hlv 996 Bacteriocin helveticin-J UniProtKB: P22294 L. paragasseri strain NCTC 13,720 (98.09%), L. gasseri 
strain EJL (97.89%)
lafA 228 Bacteriocin lactacin-F subunit LafA UniProtKB: P24022
NCBI: LJ_RS03150
L. gasseri strain EJL (100%), L. gasseri strain 151–2 (100%)
lafX 198 Bacteriocin lactacin-F subunit LafX UniProtKB: Q48509 L. gasseri strain EJL (100%), L. gasseri strain 151–2 (100%)
Page 18 of 24Mann et al. Microb Cell Fact           (2021) 20:75 
100  °C) [98]. These 2 bacteroicins are good candidate 
biopreservatives.
The whole genome sequence of L. gasseri HHuMIN D 
was verified through CLgenomicsTM and EZBioCloud 
applications to see if this strain qualifies for GRAS sta-
tus. All results are summarized in Table  9. We found 
that the antimicrobial activity against oral harmful 
bacteria may be the result of one or more of three bac-
teriocin genes in which the antimicrobial activity of L. 
gasseri HHuMIN D was found: hlv, lafA, lafX. The hel-
veticin J from L. gasseri HHuMIN D showed 98.09% 
homology with helveticin from L. paragasseri strain 
NCTC13720, and 97.89% homology with helveticin 
from L. gasseri strain EJL. The lactacin-F (subunit 
Fig. 9 Biosynthetic pathways of different biogenic amines by L. gasseri HHuMIN D. Solid arrows indicate that the biosynthesis pathways of biogenic 
amine is effective and dashed arrows indicate invalid: TYDC tyrosine decarboxylase, DDC/TDC L-tryptophan decarboxylase, ldcC/cadA lysine 
decarboxylase, hdc HDC, histidine decarboxylase, glsA/GLS glutaminase, CPS1 carbamoyl-phosphate synthase, OTC/argF/argI ornithine carbamoyl 
transferase, argG/ASS1 argininosuccinate synthase, argH/ASL argininosuccinate lyase, rocF/arg arginase, ODC1/speC/speF ornithine decarboxylase, 
PAO/FMS1 polyamine oxidase, SMS spermine synthase, speE/SRM/SPE3 spermidine synthase, and metK S-adenosylmethionine synthetase. Whole 
genome sequencing of L. gasseri HHuMIN D was performed by Chunlab, Inc. (Seoul, Korea), which used PacBio Sequel Systems (Pacific Biosciences, 
Menlo Park, CA, USA) and analyzed using CLgenomics™ and EZBioCloud Apps programs (Chunlab, Seoul, Korea). Biosynthetic pathways of 
different biogenic amines were analyzed by matching with the KEGG pathway using complete genome sequencing of L. gasseri HHuMIN D via CL 
Genomics™ (ChunLab, Seoul, South Korea, 2004). The activities of related genes and substances produced can be inferred through the biosynthetic 
pathways provided by KEGG
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LafA and subunit LafX) from L. gasseri HHuMIN D 
showed 100% homology with lactacin-F from L. gasseri 
strain EJL and L. gasseri strain 151–2. The WGS can-
not determine which of these genes are responsible 
for inhibitory activity against the pathogens tested and 
there is no data for reference because there are insuf-
ficient screening studies on bacteriocins produced by 
L. gasseri HHuMIN D against harmful oral bacteria. 
Further studies on bacteriocins produced by L. gasseri 
HHuMIN D and their effects on harmful oral bacteria 
are needed.
The whole genome sequence of L. gasseri HHuMIN D 
was scanned via the CLgenomicsTM and EZBioCloud 
applications for genes that generate enzymes engaged in 
the metabolic pathways that create biogenic amines. Fig-
ure 9 demonstrates the biosynthetic mechanism of differ-
ent biogenic amines.
No genes were identified that produce tyrosine decar-
boxylase (which generates tyramine from tyrosine), 
L-tryptophan decarboxylase (which generates tyramine 
from tyrosine, histamine from histidine, tryptamine 
from tryptophan, and phenylethylamine from phenylala-
nine), lysine decarboxylase (which generates cadaverine 
from lysine), histidine decarboxylase (which generates 
histamine from histidine), carbamoyl-phosphate syn-
thase (which generates ornithine from NH3), ornithine 
carbamoyl transferase (which generates citruline from 
ornithine), argininosuccinate synthase (which generates 
L-arginosuccinate from citruline), argininosuccinate 
lyase (which generates arginine from L-arginosuccinate), 
arginase (which generates ornithine from arginine), poly-
amine oxidase (which generates putrescine from sper-
midine), spermine synthase (which generates spermine 
from spermidine), spermidine synthase (which gener-
ates methylthioadenosine from S-adenosylmethionine) 
(Fig. 9), and genes were identified that produce glutami-
nase (which generates NH3 from glutamine), ornithine 
decarboxylase (which generates putrescine from ornith-
ine), S-adenosylmethionine synthetase (which generates 
S-adenosylmethionine from methionine) (Fig. 9).
Glutamine can be converted to NH3 through glsA or 
GLS and converted NH3 can be converted to ornithine 
through CPS1. As a result of confirming the mechanism, 
L. gasseri HHuMIN D can be converted from glutamine 
to NH3 via glsA or GLS but cannot be converted to 
ornithine since there is no CPS1 thereafter. If ornithine 
exists, it can be converted via the urea cycle into citri-
uline, L-arginosuccinate, and arginine; the associated 
genes have not been found in the L. gasseri HHuMIN D 
genome. Polyamines such as putrescine, spermidine and 
spermine are produced using ornithine as the starting 
substrates through different pathways (Fig. 9). Except for 
methionine adenosyltransferase (MAT) and putrescine 
biosynthetic genes (ODC1, speC, speF), no genes encod-
ing polyamine biosynthetic enzymes were found in the 
L. gasseri HHuMIN D genome. Contrary to the genetic 
Fig. 10 Glycine, serine, and threonine metabolism pathways of L. gasseri HHuMIN D. Solid arrows indicate that the metabolism pathways 
of glycine, serine, and threonine are effective and dashed arrows indicate invalid: sdaA/sdaB/tdcG L-serine dehydratase, glyA/SHMT glycine 
hydroxymethyltransferase, AGXT alanine-glyoxylate transaminase, glxK/garK glycerate 2-kinase, serA/PHGDH D-3-phosphoglycerate dehydrogenase, 
serC/PSAT1 phosphoserine aminotransferase, serB/PSPH phosphoserine phosphatase, thrH/phosphoserine homoserine phosphotransferase, CBS 
cystathionine beta-synthase, CHO1/pssA CDP-diacylglycerol–-serine O-phosphatidyltransferase, trpA tryptophan synthase alpha chain; and trpB, 
tryptophan synthase beta chain. Whole genome sequencing of L. gasseri HHuMIN D was performed by Chunlab, Inc. (Seoul, Korea), which used 
PacBio Sequel Systems (Pacific Biosciences, Menlo Park, CA, USA) and analyzed using CLgenomics™ and EZBioCloud Apps programs (Chunlab, 
Seoul, Korea). Biosynthetic pathways of glycine, serine, and threonine were analyzed by matching with the KEGG pathway using complete genome 
sequencing of L. gasseri HHuMIN D via CL Genomics™ (ChunLab, Seoul, South Korea, 2004). The activities of related genes and substances produced 
can be inferred through the biosynthetic pathways provided by KEGG
Page 20 of 24Mann et al. Microb Cell Fact           (2021) 20:75 
results, the production amount seems to be very small, as 
bioamines are not measured in BA production capacity 
evaluation.
Phosphatidylserine plays a crucial role in the devel-
opment of blood clotting and thrombus, so the genes 
involved in the metabolic pathways that create this com-
pound were evaluated. L. gasseri HHuMIN D does not 
have any genes that produce phosphatidylserine in the 
metabolic pathway (Fig. 10).
Virulence genes lend pathogenicity to microorganisms. 
L. gasseri HHuMIN D was assumed to be non-patho-
genic using VirulenceFinder 2.0, a program that enables 
pathogenic and non-pathogenic bacteria to be differ-
entiated using data from the whole genome sequence 
in order to classify potential virulence genes within the 
genome. The L. gasseri HHuMIN D genome sequence 
was compared with the genomic sequences of four noted 
pathogens (Escherichia coli, Enterococcus, Listeria, and 
Staphylococcus aureus). Virulence factors evaluated 
included Escherichia coli shiga toxin gene and Staphy-
lococcus aureus exoenzyme genes, host immune altera-
tion or evasion genes and toxin genes. The L. gasseri 
HHuMIN D genomic sequencing revealed no virulence 
factors or toxic or pathogenic genes.
L. gasseri HHuMIN D genes related to antibiotic resist-
ance were discovered using the ideal and strict algorithms 
of CARD (Table 10). The genome of L. gasseri HHuMIN 
D was found to contain 16 putative genes associated with 
resistance to beta-lactams (7), bacitracin (1), aminoglyco-
side (1), aminocoumarin (1), lincomycin (1), polymyxin 
(1), macrolide (2) and multi antibiotic (2). Antibiotic 
resistance assays showed that L. gasseri HHuMIN D 
was resistant to gentamicin, streptomycin, and kana-
mycin, but genes associated with antibiotic resistance 
were not detected. Although penicillin, bacitracin, and 
lincomycin genes linked to resistance have been identi-
fied, the organism itself has demonstrated low resistance 
in antibiotic resistance assays. It must be noted that the 
L. gasseri HHuMIN D genome and the phenotype for 
antibiotic resistance do not match completely. It should 
be considered that the L. fermentum OK genome and 
the phenotypes of antibiotic resistance may not exactly 
fit. For DNA replication, GyrA is necessary. Multidrug 
efflux transporters are involved in several detoxifying 
activities in cells and are widely distributed across many 
forms of Lactobacillus spp. [89]. There are also safety fac-
tors regarding the use of antibiotic-resistant strains, due 
to the possibility of transferring antibiotic-resistance 
Table 10 Putative antibiotic resistance genes in the L. gasseri HHuMIN D genome
Gene ID Name Length COG_name KEGG_name Product Category
HHuMIN D_00032 GLIA 1452 2814 22,134 multidrug resistance protein multi antibiotic resistance gene
HHuMIN D_00185 cusR, copR, silR 666 0745 07,665 transcriptional regulatory protein beta-lactam antibiotic resistance gene
HHuMIN D_00391 mdlB, smdB 1794 1132 18,890 probable multidrug resistance ABC 
transporter ATP-binding/per-
mease protein YheH
multi antibiotic resistance gene
HHuMIN D_00573 aacC 810 2746 00,662 aminoglycoside N(3)-acetyltrans-
ferase
aminoglycoside antibiotic resistance 
gene
HHuMIN D_00588 mrcA 2379 0744 05,366 peptidoglycan glycosyltransferase beta-lactam antibiotic resistance gene
HHuMIN D_00697 pbpB 2151 0768 08,724 penicillin-binding protein 2B beta-lactam antibiotic resistance gene
HHuMIN D_00746 sotB 1383 0477 08,159 lincomycin resistance protein LmrB lincomycin antibiotic resistance gene
HHuMIN D_00878 mrdA 2100 0768 05,515 serine-type D-Ala-D-Ala carboxy-
peptidase
beta-lactam antibiotic resistance gene
HHuMIN D_01245 gtrB, csbB 933 0463 20,534 undecaprenyl-phosphate 4-deoxy-
4-formamido-L-arabinose 
transferase
polymyxin antibiotic resistance gene
HHuMIN D_01314 parE 1959 0187 02,622 DNA gyrase subunit aminocoumarin antibiotic resistance 
gene
HHuMIN D_01342 abcA, bmrA 996 1132 18,104 xenobiotic-transporting ATPase beta-lactam antibiotic resistance gene
HHuMIN D_01640 ddpF 678 1136 02,032 macrolide export ATP-binding/per-
mease protein MacB
macrolide antibiotic resistance gene
HHuMIN D_01864 pbp1b 2829 0744 03,693 penicillin-binding protein 1A beta-lactam antibiotic resistance gene
HHuMIN D_01995 ABC.CD.P 1869 0577 02,004 bacitracin export permease protein 
BceB
bacitracin antibiotic resistance gene
HHuMIN D_02034 cpoA 1044 0438 13,678 alpha-galactosylglucosyldiacylglyc-
erol synthase
beta-lactam antibiotic resistance gene
HHuMIN D_02075 metN 690 1135 02,071 macrolide export ATP-binding/per-
mease protein MacB
macrolide antibiotic resistance gene
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genes to intestinal pathogens [99]. Consequently, whole 
genome sequencing was used to determine whether 
the antibiotic-resistant genes of L. gasseri HHuMIN D 
could be transmitted through plasmids to other bacte-
ria. No gene capable of delivering antibiotic resistance 
in the whole genome of L. gasseri HHuMIN D was found 
(data not shown). Since genes cannot be spread, antibi-
otic resistance to L. gasseri HHuMIN D is known to be 
inherent or normal. Several studies have documented 
that tolerance to aminoglycoside groups such as gen-
tamicin, streptomycin, kanamycin and neomycin is sus-
pected to be intrinsic to Lactobacillus spp. and is due to 
the absence of cytochrome-mediated electron transport 
that mediates drug absorption [100, 101].
Conclusion
Oral microorganisms can be classified into anaerobic 
microorganisms and aerobic microorganisms (includ-
ing facultative  anaerobes), based on their sensitivity to 
oxygen. Anaerobic microorganisms generally live in 
environments where oxygen penetration is minimal or 
nonexistent, such as gingival crevices or periodontal 
pockets, and induce diseases such as halitosis and peri-
odontitis. Aerobic microorganisms mainly inhabit the 
buccal and palatal mucosae, especially the tongue, and 
some species form biofilms to settle oral microorgan-
isms and provide an environment in which diseases 
such as tooth decay can be induced. Most Streptococcus 
spp. do not induce disease and are commonly found in 
the oral cavity. We sought to confirm the effects of the 
probiotics isolated in this study using 11 types of oral 
microorganisms that included general aerobic micro-
organisms, disease-inducing aerobic microorganisms, 
and disease-inducing anaerobic microorganisms. L. gas-
seri HHuMIN D culture supernatant inhibited halito-
sis producing anaerobic microorganisms by 88.8% and 
antimicrobial activity against deleterious oral bacteria 
was strong. Multiplication of L. gasseri HHuMIN D was 
impaired when co-cultured with other oral bacteria. L. 
gasseri HHuMIN D continuously released hydrogen per-
oxide after 12 h to 802 μmol/L and gradually decreased 
until 24 h. P. catoniae, and S. sanguinis were aggregated 
with L. gasseri HHuMIN D, and L. gasseri HHuMIN D 
decreased the manufacture of artificial dental plaque 
from S. mutans by 100%. The KB cell adhesion ability of 
L. gasseri HHuMIN D was 4.41 cells per cell and the cell 
adhesion of F. nucleatum and S. mutans decreased dra-
matically in protection and displacement assays. These 
characteristics of L. gasseri HHuMIN D are thought to 
indirectly help inhibit harmful oral microorganisms. L. 
gasseri HHuMIN D showed direct inhibitory effects on 
the growth of oral pathogens. L. gasseri HHuMIN D does 
not produce biogenic amines and ammonia, hemolysis 
and mucin decomposition activity were not observed and 
antibiotic resistance testing and WGS analysis confirmed 
that there was no antibiotic resistance or genes associ-
ated with biogenic amines, platelet aggregation, virulence 
or antibiotic resistance. Three genes that express bacte-
riocin were identified. These assessments demonstrated 
compliance of the L. gasseri HHuMIN D with EFSA and 
FDA requirements and this study suggests that L. gasseri 
HHuMIN D may be effective in inhibiting harmful oral 
bacteria and has potential for use as a natural probiotic, a 
functional food, or a food for wellbeing.
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